Effect of Growth Stage on the Relationship Between Tan Spot and Spot Blotch Severity and Yield in Winter Wheat

Foliar fungal diseases frequently cause significant economic losses in the hard red winter wheat production areas of the Great Plains of the United States. In 2007, field experiments were conducted in four environments in Nebraska, USA to determine the crop growth stage at which severity of tan spot and spot blotch was most strongly related to yield in winter wheat. Secondary objectives were to evaluate the efficacy of fungicides in controlling tan spot and spot blotch and to determine the effect of fun¬gicide application timing on disease intensity and yield. Disease severity assessed at Zadoks growth stage (ZGS) 60 (flower¬ing) had the strongest relationship to yield at all four locations (0.72 ≤ R2 ≤ 0.90, P \u3c 0.0001). Disease severity assessed at ZGS 71 (kernel watery ripe) also was strongly related to yield (0.54 ≤ R2 ≤ 0.87, P ≤ 0.0011), but not as consistently across the four loca¬tions as disease severity assessed at ZGS 60. The relationship between yield and area under the disease progress curve (AUDPC) (0.43 ≤ R2 ≤ 0.80, P ≤ 0.0055) was weaker and less consistent across the four locations than the relationship between yield and dis¬ease severity assessed at ZGS 60 or ZGS 71. Disease progress was faster at Mead (southeast) and Clay Center (south central) than at North Platte (west central) and Sidney (west). The fungicides azoxystrobin, pyraclostrobin, propiconazole, azoxystrobin plus propiconazole, and trifloxystrobin plus propiconazole effectively reduced disease severity and AUDPC. Out of a total of 60 fun¬gicide treatments at four locations, 98%, 100%, and 100% significantly (P = 0.05) reduced disease severity, reduced AUDPC, and increased yield, respectively, compared to the check. Yield losses ranging from 27% to 42% were prevented by fungicide applica¬tions. There was no consistent effect on disease intensity or on yield of timing fungicide applications at ZGS 31 (first node on the stem detectable) versus ZGS 39 (ligule/collar of flag leaf just visible). The results from this study suggest that (i) the best predic¬tor of yield loss caused by tan spot and spot blotch in winter wheat in Nebraska is disease severity assessed at flowering and (ii) fungicides can prevent significant yield losses from tan spot and spot blotch in winter wheat

National action plans for antimicrobial resistance and variations in surveillance data platforms

Objective To assess how national antimicrobial susceptibility data used to inform national action plans vary across surveillance platforms. Methods We identified available open-access, supranational, interactive surveillance platforms and cross-checked their data in accordance with the World Health Organization’s (WHO’s) Data Quality Assurance: module 1. We compared platform usability and completeness of time-matched data on the antimicrobial susceptibilities of four blood isolate species: Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae from WHO’s Global Antimicrobial Resistance and Use Surveillance System, European Centre for Disease Control’s (ECDC’s) network and Pfizer’s Antimicrobial Testing Leadership and Surveillance database. Using Bland–Altman analysis, paired t-tests, and Wilcoxon signed-rank tests, we assessed susceptibility data and number of isolate concordances between platforms. Findings Of 71 countries actively submitting data to WHO, 28 also submit to Pfizer’s database; 19 to ECDC; and 16 to all three platforms. Limits of agreement between WHO’s and Pfizer’s platforms for organism–country susceptibility data ranged from −26% to 35%. While mean susceptibilities of WHO’s and ECDC‘s platforms did not differ (bias: 0%, 95% confidence interval: −2 to 2), concordance between organism–country susceptibility was low (limits of agreement −18 to 18%). Significant differences exist in isolate numbers reported between WHO–Pfizer (mean of difference: 674, P-value: < 0.001 and WHO–ECDC (mean of difference: 192, P value: 0.04) platforms. Conclusion The considerable heterogeneity of nationally submitted data to commonly used antimicrobial resistance surveillance platforms compromises their validity, thus undermining local and global antimicrobial resistance strategies. Hence, we need to understand and address surveillance platform variability and its underlying mechanisms

Congenital anomalies: Impact of prenatal diagnosis on mode of delivery.

An important aspect of prenatal diagnosis is the avoidance of emergency caesarean delivery (CD) where the abnormality is considered lethal and the infant will not survive. A consecutive cohort of 211,163 women delivered of infants weighing 500 grams or more in three tertiary referral centers from 01/95 to 12/04, was analyzed for perinatal death attributed to congenital malformations. In the group that died in the neonatal period, the emergency CD rate was significantly lower where anomaly was detected versus undetected (17.5% versus 31%). Further, in contrast to undiagnosed anomalies, the indication for emergency CD was more often maternal in the diagnosed group (42% versus 19%, p=0.019). When a diagnosis of lethal congenital anomaly has been made in the prenatal period, the reduction in the emergency CD rate by almost half in this study supports a pivotal role for prenatal diagnosis in optimizing maternal care

Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer

Objective The therapeutic benefits of poly(ADP-ribose) polymerase inhibitors highlight the need to evaluate BRCA1/2 defects in tubal/ovarian cancer (OC). We sought to determine the pattern and disease characteristics associated with tumor BRCA1/2 mutations and BRCA1 methylation in women with OC. Methods We obtained 111 OC specimens from 2 university hospitals and assessed BRCA1/2 mutations and BRCA1 methylation in tumor DNA. The frequency and pattern of BRCA1/2 defects were examined. Associations between patient/disease characteristics and BRCA1/2 defects were ascertained (Fisher’s exact test). Platinum-free interval (PFI), progression-free survival (PFS), and overall survival (OS) based on the underlying BRCA1/2 defect were determined (Kaplan-Meier analysis [log-rank test]). Results We observed a BRCA1/2 dysfunction rate of 40% (28/70) in high-grade serous tubal/ovarian cancer (HGSC), including 14.3% BRCA1 methylation (n=10), 7.1% BRCA1 mutation (n=5), and 18.6% BRCA2 mutation (n=13). Defects in BRCA1/2 genes were associated with stage III/IV HGSC (BRCA1 methylation: P=0.005 [stage III/IV] and P=0.004 [HGSC]; BRCA1/2 mutation: P=0.03 [stage III/IV] and P<0.001 [HGSC]). Patients with BRCA1/2-mutated cancers showed improved OS (hazard ratio [HR], 0.65; 95% confidence interval [CI], 0.43–0.99; P=0.045) and a trend toward improved PFI (HR, 0.48; 95% CI, 0.22–1.06; P=0.07) and PFS (HR, 0.72; 95% CI, 0.51–1.03; P=0.07). No survival differences were observed between BRCA1-methylated and BRCA1/2 wild-type non-BRCA1-methylated cancers. Conclusion We observed a high tumor BRCA1/2 dysfunction rate in HGSC with a unique predominance of BRCA2 over BRCA1 mutations. While BRCA1/2 mutations conferred survival benefits in OC, no such association was observed with BRCA1 methylation

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

BACKGROUND: Influenza A viruses cause occasional pandemics and frequent epidemics. Licensed influenza vaccines that induce high antibody titers to the highly polymorphic viral surface antigen hemagglutinin must be re-formulated and readministered annually. A vaccine providing protective immunity to the highly conserved internal antigens could provide longer-lasting protection against multiple influenza subtypes. METHODS: We prepared a Modified Vaccinia virus Ankara (MVA) vector encoding nucleoprotein and matrix protein 1 (MVA-NP+M1) and conducted a phase I clinical trial in healthy adults. RESULTS: The vaccine was generally safe and well tolerated, with significantly fewer local side effects after intramuscular rather than intradermal administration. Systemic side effects increased at the higher dose in both frequency and severity, with 5 out of 8 volunteers experiencing severe nausea/vomiting, malaise, or rigors. Ex vivo T-cell responses to NP and M1 measured by IFN-γ ELISPOT assay were significantly increased after vaccination (prevaccination median of 123 spot-forming units/million peripheral blood mononuclear cells, postvaccination peak response median 339, 443, and 1443 in low-dose intradermal, low-dose intramuscular, and high-dose intramuscular groups, respectively), and the majority of the antigen-specific T cells were CD8(+). CONCLUSIONS: We conclude that the vaccine was both safe and remarkably immunogenic, leading to frequencies of responding T cells that appear to be much higher than those induced by any other influenza vaccination approach. Further studies will be required to find the optimum dose and to assess whether the increased T-cell response to conserved influenza proteins results in protection from influenza disease

Co-evolution of cerebral and cerebellar expansion in cetaceans.

Cetaceans possess brains that rank among the largest to have ever evolved, either in terms of absolute mass or relative to body size. Cetaceans have evolved these huge brains under relatively unique environmental conditions, making them a fascinating case study to investigate the constraints and selection pressures that shape how brains evolve. Indeed, cetaceans have some unusual neuroanatomical features, including a thin but highly folded cerebrum with low cortical neuron density, as well as many structural adaptations associated with acoustic communication. Previous reports also suggest that at least some cetaceans have an expanded cerebellum, a brain structure with wide-ranging functions in adaptive filtering of sensory information, the control of motor actions, and cognition. Here, we report that, relative to the size of the rest of the brain, both the cerebrum and cerebellum are dramatically enlarged in cetaceans and show evidence of co-evolution, a pattern of brain evolution that is convergent with primates. However, we also highlight several branches where cortico-cerebellar co-evolution may be partially decoupled, suggesting these structures can respond to independent selection pressures. Across cetaceans, we find no evidence of a simple linear relationship between either cerebrum and cerebellum size and the complexity of social ecology or acoustic communication, but do find evidence that their expansion may be associated with dietary breadth. In addition, our results suggest that major increases in both cerebrum and cerebellum size occurred early in cetacean evolution, prior to the origin of the major extant clades, and predate the evolution of echolocation

A survey by hydraulic dredge of interstitial bivalves with commercial potential in Cill Chiaráin and Beirtreach buí Bays and along their connecting shoreline, Co Galway

The shellfish co-operative, Comharchuman Sliogéisc Chonamara Teó (CSC) manages oyster and scallop in Beirtreach buí and Cill Chiaráin Bays, both of which are designated aquaculture areas. Cill Chiaráin is also a candidate Special Area of Conservation (cSAC). Various traditional fishing activities are carried on in the bays and CSC has rights to exploit clam species there. The work described here is a survey of interstitial clam species by hydraulic dredge between November 2001 and January 2002. Investigations were restricted from some of the upper bay areas where surface bivalve management was in progress. Much of the remaining areas within the Bays proved unsuitable for hydraulic dredging by virtue of the nature of the substratum. The exposed parts of the lower bays and the intervening coastline where the substratum was coarse sand (maërl or shell sand) were suitable for hydraulic dredging but bedrock and loose boulders often proved obstacles to towing. There was evidence of two assemblages of bivalves in the bays: one typified by Venus verrucosa, Venerupis senegalensis and Tapes rhomboides, all large and potentially valuable, occurred within maërl mixed with fine mud, the other whose most valuable components included Ensis arcuatus and Spisula solida, occurred in disintegrating maërl and in shell sand. The bivalve fauna in the two bays appeared to be typified by relatively high diversity and low biomass – which is accentuated by recent natural mortalities of Ensis arcuatus, a dominant species - and this is likely to prove a challenge to marketing; the Irish market typically exploits small numbers of clam species simultaneously. The terms of the licence under which CSC operates may provide opportunities to exploit clams within their designated area by means other than hydraulic dredging and these should be investigated. In view of the scientific values of the area and its status as a cSAC any plan to exploit its interstitial bivalves should be discussed with the relevant state agency.Funder: Marine Institut